Search

Your search keyword '"Michael E, Carney"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Michael E, Carney" Remove constraint Author: "Michael E, Carney" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
50 results on '"Michael E, Carney"'

Search Results

1. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

2. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

3. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma

4. A fight-and-flight for life: A rare case of advanced cervical cancer in pregnancy

5. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

6. Figure S3 from Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

7. Supplementary Figures 1-5, Tables 1-8 from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

8. Data from Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

9. Data from Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium

10. Data from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

11. Supplemental Tables from Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

12. Supplementary Tables 1-2 from Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium

13. Supplemental Figure Legends from Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer

14. Supplementary Table 4 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

15. Data from Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer

16. Supplementary Figure 1 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

17. Supplementary Tables 1-4 from Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer

18. Supplementary Table 2 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

19. Supplementary Table 3 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

20. Supplementary Figure 2 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

21. Data from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

22. Supplementary Table 1 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

23. Two Cases of Mesonephric-like Carcinoma Arising From Endometriosis: Case Report and Review of the Literature

24. Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 + TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

25. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

26. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

27. Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer

28. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women

29. Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies

30. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

31. Identification of a Locus Near

32. Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations

33. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

34. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

35. A Case of Human Papilloma Virus 31- and 68-Associated Metastatic Squamous Cell Carcinoma of the Cervix in a Healthy 28-Year-Old Woman

36. A Case of High-Grade Endometrial Stromal Sarcoma with Concurrent Pregnancy

37. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium

38. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

39. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

40. A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer

41. A fight-and-flight for life: A rare case of advanced cervical cancer in pregnancy

42. Low-Volume Lymph Node Metastases in Endometrial Carcinoma

43. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

44. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk

45. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

46. Thirty-day readmissions following surgery for cancer of the ovary

47. Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer

48. A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study

49. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci

50. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk

Catalog

Books, media, physical & digital resources